Insider Buying: CRISM Therapeutics Corporation (LON:CRTX) Insider Purchases £199,398.16 in Stock April 8, 2025 by InsiderTrades.com Share CRISM Therapeutics Corporation (LON:CRTX - Get Free Report) insider Gerald Beaney purchased 20,182 shares of the firm's stock in a transaction on Monday, April 7th. The shares were purchased at an average price of GBX 988 ($12.58) per share, with a total value of £199,398.16 ($253,816.40). CRISM Therapeutics Stock PerformanceLON CRTX opened at GBX 8.11 ($0.10) on Tuesday. The stock has a 50-day simple moving average of GBX 7.23 and a 200 day simple moving average of GBX 8.78. CRISM Therapeutics Corporation has a twelve month low of GBX 5 ($0.06) and a twelve month high of GBX 30.90 ($0.39). The stock has a market capitalization of £883,524.59, a PE ratio of -1.40 and a beta of 0.81. CRISM Therapeutics Company Profile (Get Free Report)CRISM Therapeutics Corporation has developed an innovative drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. ChemoSeed, CRISM's lead product, can be implanted directly into the tumour or the resection margin following the removal of a tumour.Recommended StoriesFive stocks we like better than CRISM TherapeuticsHow to Invest in Blue Chip StocksOptions Activity Points to More Volatility for Palantir StockHow to Use the MarketBeat Stock Screener NVIDIA Stock: Oversold, Undervalued — How Low Can It Go?How to Most Effectively Use the MarketBeat Earnings ScreenerMicroStrategy Sees Insider Buy-Sell Action in Q1This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com. Insider Buying or Selling at CRISM Therapeutics? Sign-up to receive InsiderTrades.com's daily insider buying and selling report for CRISM Therapeutics and related companies. More From MarketBeatElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThe 12 Most-Hated Stocks on Wall StreetWall Street research analysts must be the most optimistic people on earth. They give "buy" ratings to more tha...MarketBeatGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored7 Tech Stocks That Still Offer Good Value for 2025Technology stocks continue to outperform most of the other market sectors. And, even though many investors may...MarketBeat$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored10 Best Small Cap Stocks to Buy NowLet's talk about small cap stocks. It's common knowledge that tilting your stock portfolio toward smaller-capi...MarketBeatGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored7 Dividend Achievers That Have Strong UpsideDividend stocks give investors the benefit of receiving consistent, passive income inside a growth investment....MarketBeat Free Insider Buying and Selling Newsletter Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report. From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Most Read This MonthTop 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldCasey’s General Stores Insider Buys Shares of This Must-Own StockMicroStrategy Sees Insider Buy-Sell Action in Q1Insider Buying in This Stock Reiterates Analysts Bullish OutlookHuntington Bancshares Incorporated (NASDAQ:HBAN) Insider Sells $347,731.92 in StockCasey's General Stores, Inc. (NASDAQ:CASY) Insider Katrina S. Lindsey Sells 250 SharesAccenture plc (NYSE:ACN) Insider Angela Beatty Sells 169 SharesInsider Selling: Roku, Inc. (NASDAQ:ROKU) CAO Sells $14,649.39 in StockRecent ArticlesKirill Klip Sells 200,000 Shares of TNR Gold Corp. (CVE:TNR) StockInsider Buying: Blue Moon Metals Inc. (CVE:MOON) Senior Officer Acquires 3,891 Shares of StockFirst Mining Gold Corp. (TSE:FF) Director Leanne Bernice Hall Acquires 65,000 SharesInsider Selling: K9 Gold Corp. (CVE:KNC) Director Sells 100,000 Shares of StockCohen & Steers Quality Income Realty Fund, Inc. (NYSE:RQI) VP Sells $11,922.88 in StockSlam Exploration Ltd. (CVE:SXL) Insider Bruce Macdonald Buys 500,000 SharesTurtle Creek Asset Management Acquires 2,856 Shares of JELD-WEN Holding, Inc. (NYSE:JELD) StockDaniel Earl Smith Purchases 1,000 Shares of CTO Realty Growth, Inc. (NYSE:CTO) Stock
